Oxford Immunotec Global PLC (NASDAQ:OXFD) has scheduled a conference call for 4th August 2020 at 8:00 AM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.oxfordimmunotec.com
Earnings Expectation
Oxford Immunotec Global PLC is reporting second quarter earnings results on Tuesday 4th August 2020, before market open. The consensus estimates from Thomson Reuters are loss of $ 0.3 per share from $ 5.80 million in revenue. For the full year, analysts predict revenues of $ 53.89 million, while looking forward to loss of $ 0.61 per share.
The Company Outlook
Revenue for 2Q20 are expected in a range of $ 5.00 million ~ $ 6.00 million
Full Year 2020 topline are forecasted in a range of$ 78.00 million ~ $ 81.00 million
Click Here For More Historical Outlooks Of Oxford Immunotec Global PLC
Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States. It develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. The company develops and markets T-SPOT.TB test used to test for tuberculosis.
